Alvotech (ALVO) Receivables (2020 - 2026)
Alvotech (ALVO) posted Receivables of $48.5 million for Q1 2026, down 30.91% on a QoQ basis from $70.2 million in Q4 2025, and down 71.22% year-over-year from $168.5 million in Q1 2025.
Alvotech (ALVO) Receivables (2020 - 2026) Analysis & Trends
Alvotech's Receivables history runs 7 years deep, the most recent figure standing at $48.5 million for Q1 2026.
- Quarterly Receivables fell 71.22% year-over-year to $48.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.5 million (down 71.22% YoY) and the FY2025 annual result came in at $191.4 million, up 19.17% from the prior year.
- Receivables was $48.5 million for Q1 2026 at Alvotech, down from $70.2 million in the prior quarter.
- Across five years, Receivables topped out at $168.5 million in Q1 2025 and bottomed at $6.8 million in Q2 2022.
- A 5-year average of $70.2 million and a median of $59.3 million in 2025 frame the typical range for Receivables.
- Annual changes were most pronounced in 2024 — Receivables soared 421.14% — and 2026, when it tumbled 71.22%.
- Alvotech's Receivables stood at $28.2 million in 2022, then soared by 66.31% to $46.9 million in 2023, then jumped by 92.68% to $90.4 million in 2024, then decreased by 22.39% to $70.2 million in 2025, then slumped by 30.91% to $48.5 million in 2026.
- Business Quant data shows ALVO's Receivables at $48.5 million in Q1 2026, $70.2 million in Q4 2025, and $151.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 48.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.49 Mn |
| Dec 31, 2025 | 70.18 Mn |
| Sep 30, 2025 | 151.85 Mn |
| Jun 30, 2025 | 108.28 Mn |
| Mar 31, 2025 | 168.49 Mn |
| Dec 31, 2024 | 90.43 Mn |
| Sep 30, 2024 | 77.46 Mn |
| Jun 30, 2024 | 93.61 Mn |
| Mar 31, 2024 | 42.29 Mn |
| Dec 31, 2023 | 46.93 Mn |
| Jun 30, 2023 | 17.96 Mn |
| Mar 31, 2023 | 31.57 Mn |
| Dec 31, 2022 | 28.22 Mn |
| Jun 30, 2022 | 6.80 Mn |
| Dec 31, 2021 | 20.55 Mn |
| Dec 31, 2020 | 34.72 Mn |